abstract |
The present invention relates to modified siRNA compounds that down regulate target gene expression, pharmaceutical compositions comprising such compounds, and various diseases or conditions associated with said genes and / or the occurrence of symptoms associated with such diseases or conditions or It relates to a method for treating and / or preventing severity. |